Roche Holding Ltd Insider Trades

Insider Trading History

Track insider trading activity for Roche Holding Ltd. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Aligos Therapeutics
Aligos Therapeutics ALGS
10% owner
Holding Value $58M 11,025,941 shares
Last Trade
Oct 25, 2023 Sale
$61M 3,966,800 shares
$15.37
$5.26
Jasper Therapeutics- Warrants (24/09/2026)
Jasper Therapeutics- Warrants (24/09/2026) JSPRW
Director
Holding Value $66.4k 4,549,606 shares
Last Trade
Jan 25, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.08k 75,000 shares
$0.12
$0.01
Jasper Therapeutics
Jasper Therapeutics JSPR
Director
Holding Value $2.19M 4,549,606 shares
Last Trade
Jan 25, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.39M 75,000 shares
$18.50
$0.48
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $19.7M 2,813,525 shares
Last Trade
Nov 02, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$8.11M 318,140 shares
$25.48
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $0 0 shares
Last Trade
Nov 02, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$63.6M 2,495,385 shares
$25.48
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $0 0 shares
Last Trade
Nov 02, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$8.11M 318,140 shares
$25.48
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $17.5M 2,495,385 shares
Last Trade
Nov 02, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$63.6M 2,495,385 shares
$25.48
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 28, 2021 Sale
No data
No data
$7.00
Entrada Therapeutics
Entrada Therapeutics TRDA
10% owner
Holding Value $0 0 shares
Last Trade
Oct 28, 2021 Sale
No data
No data
$7.00
Allakos
Allakos ALLK
10% owner
Holding Value $0 0 shares
Last Trade
Jul 23, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$149M 4,108,091 shares
$36.29
$0.33
Allakos
Allakos ALLK
Director
Holding Value $1.52M 4,610,723 shares
Last Trade
Jul 23, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$167M 4,610,723 shares
$36.29
$0.33
Allakos
Allakos ALLK
Director
Holding Value $0 0 shares
Last Trade
Jul 23, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$149M 4,108,091 shares
$36.29
$0.33
Allakos
Allakos ALLK
10% owner
Holding Value $0 0 shares
Last Trade
Jul 23, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$18.2M 502,632 shares
$36.29
$0.33
Allakos
Allakos ALLK
Director
Holding Value $0 0 shares
Last Trade
Jul 23, 2018 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$18.2M 502,632 shares
$36.29
$0.33
Allakos
Allakos ALLK
10% owner
Holding Value $1.52M 4,610,723 shares
Last Trade
Jul 23, 2018 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$167M 4,610,723 shares
$36.29
$0.33
Allakos
Allakos ALLK
10% owner
Holding Value $0 0 shares
Last Trade
Jul 18, 2018 Sale
No data
No data
$0.33
Allakos
Allakos ALLK
10% owner
Holding Value $0 0 shares
Last Trade
Jul 18, 2018 Sale
No data
No data
$0.33
Aileron Therapeutics
Aileron Therapeutics ALRN
10% owner
Holding Value $1.48M 702,363 shares
Last Trade
Jul 05, 2017 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$29.4M 119,400 shares
$246.20
$2.11
Aileron Therapeutics
Aileron Therapeutics ALRN
10% owner
Holding Value $1.23M 582,963 shares
Last Trade
Jul 05, 2017 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$143M 579,093 shares
$246.20
$2.11

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up